Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response

International Immunology

Volumn 25, Issue 4, 2013, Pages 247-258

  Tenbusch, Matthias ^a   Nchinda, Godwin ^b,c   Bonsmann, Michael Storcksdieck Genannt ^a   Temchura, Vladimir ^a   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

^c CIRCB   (Cameroon)

Author keywords

Adenoviral vector; DC targeting; Vaccination

Indexed keywords

ADENOVIRUS VECTOR; CELL RECEPTOR; DEC205 RECEPTOR; DENDRITIC CELL VACCINE; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; L SELECTIN; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENETIC CODE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; OVALBUMIN; RECEPTORS, CELL SURFACE; SINGLE-CHAIN ANTIBODIES; T-LYMPHOCYTE SUBSETS;

EID: 84875258928     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs112     Document Type: Article

References (37)

1. Kohlmann, R., Schwannecke, S., Tippler, B. et al. 2009. Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus. J. Virol. 83:12601
2. Holman, D. H., Wang, D., Raja, N. U. et al. 2008. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 26:2627
3. Wei, C. J., Boyington, J. C., McTamney, P. M. et al. 2010. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060
4. Barouch, D. H., Pau, M. G., Custers, J. H. et al. 2004. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 172:6290
5. Shiver, J. W., Fu, T. M., Chen, L. et al. 2002. Replicationincompetent adenoviral vaccine vector elicits effective anti-immunodeficiency- virus immunity. Nature 415:331
6. Buchbinder, S. P., Mehrotra, D. V., Duerr, A. et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-ofconcept trial. Lancet 372:1881
7. McElrath, M. J., De Rosa, S. C., Moodie, Z. et al. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894
8. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C. and Steinman, R. M. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627
9. Bonifaz, L. C., Bonnyay, D. P., Charalambous, A. et al. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815
10. Idoyaga, J., Cheong, C., Suda, K. et al. 2008. Cutting edge: langerin/ CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180:3647
11. Idoyaga, J., Lubkin, A., Fiorese, C. et al. 2011. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. U.S.A. 108:2384
12. Carter, R. W., Thompson, C., Reid, D. M., Wong, S. Y. and Tough, D. F. 2006. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 177:2276
13. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M. C. and Steinman R. M. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627
14. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219
15. Hawiger, D., Masilamani, R. F., Bettelli, E., Kuchroo, V. K. and Nussenzweig, M. C. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20:695
16. Hawiger, D., Inaba, K., Dorsett, Y. et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769
17. Stern, J. N., Keskin, D. B., Kato, Z. et al. 2010. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 107:17280
18. Gurer, C., Strowig, T., Brilot, F. et al. 2008. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112:1231
19. Trumpfheller, C., Finke, J. S., López, C. B. et al. 2006. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203:607
20. Charalambous, A., Oks, M., Nchinda, G., Yamazaki, S. and Steinman, R. M. 2006. Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J. Immunol. 177:8410
21. Grossmann, C., Tenbusch, M., Nchinda, G. et al. 2009. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands. BMC Immunol. 10:43.
22. Demangel, C., Zhou, J., Choo, A. B., Shoebridge, G., Halliday, G. M. and Britton, W. J. 2005. Single chain antibody fragments for the selective targeting of antigens to dendritic cells. Mol. Immunol. 42:979
23. Nchinda, G., Kuroiwa, J., Oks, M. et al. 2008. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J. Clin. Invest. 118:1427
24. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. and Vogelstein, B. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95:2509
25. Potthoff, A., Schwannecke, S., Nabi, G. et al. 2009. Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine 27:2768
26. Tenbusch, M., Kuate, S., Tippler, B. et al. 2008. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity. BMC Immunol. 9:13.
27. Betts, M. R., Brenchley, J. M., Price, D. A. et al. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65
28. Maamary, J., Array, F., Gao, Q. et al. 2011. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice. J. Virol. 85:2235
29. Nimmerjahn, F. and Ravetch, J. V. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310:1510
30. Flynn, B. J., Kastenmüller, K., Wille-Reece, U. et al. 2011. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc. Natl. Acad. Sci. U.S.A. 108:7131
31. Victora, G. D., Schwickert, T. A., Fooksman, D. R. et al. 2010. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143:592
32. Wherry, E. J., Ha, S. J., Kaech, S. M. et al. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670
33. Yang, T. C., Millar, J., Groves, T. et al. 2006. The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J. Immunol. 176:200
34. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191
35. Huster, K. M., Busch, V., Schiemann, M. et al. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. U.S.A. 101:5610
36. Bachmann, M. F., Wolint, P., Schwarz, K., Jäger, P. and Oxenius, A. 2005. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J. Immunol. 175:4686
37. Stahl-Hennig, C., Kuate, S., Franz, M. et al. 2007. Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J. Virol. 81:13180.